The efficacy of a new on-site immunoassay drug-screening device Triage-TOX was examined.
This device was applicable to drug screening using postmortem urine and pericardial fluid.
Triage-TOX showed high sensitivity for benzodiazepines, with objective data presentation.
However, its combination with another device can help minimize misinterpretation.
Provision of systematic instrumental identification and quantification is essential.